Reduced hcv recurrent viremia in people who inject drugs (pwid) after treatment induced hcv cure

Author: 
Arshia Alimohammadi., Arpreet Singh., Tyler Raycraft., Rajvir Shahi., Ghazaleh Kiani1 and Brian Conway

We evaluated the risk of recurrent viremia in active PWID after achieving a sustained virologic response as a result of treatment in a multidisciplinary care facility, with enhanced long-term follow-up. Rates of recurrent viremia in this setting were lower compared to when treatment was implanted in a traditional clinical setting - highlighting the efficacy of this model.

Download PDF: